130 related articles for article (PubMed ID: 16260020)
1. Effect of pepsin digestion on the antivenom activity of equine immunoglobulins.
Morais V; Massaldi H
Toxicon; 2005 Dec; 46(8):876-82. PubMed ID: 16260020
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of whole serum and prepurified IgG digestion by pepsin for F(ab')2 manufacture.
Boushaba R; Kumpalume P; Slater NK
Biotechnol Prog; 2003; 19(4):1176-82. PubMed ID: 12892479
[TBL] [Abstract][Full Text] [Related]
3. A new ELISA for determination of potency in snake antivenoms.
Rial A; Morais V; Rossi S; Massaldi H
Toxicon; 2006 Sep; 48(4):462-6. PubMed ID: 16893558
[TBL] [Abstract][Full Text] [Related]
4. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of four Peruvian Bothrops sp. snake venoms by polyvalent antivenoms produced in Perú and Costa Rica: preclinical assessment.
Rojas E; Quesada L; Arce V; Lomonte B; Rojas G; Gutiérrez JM
Acta Trop; 2005 Jan; 93(1):85-95. PubMed ID: 15589801
[TBL] [Abstract][Full Text] [Related]
6. [Proteolysis of horse blood serum proteins at various stages of antitoxic sera production by the Diaferm-3 method].
Grechushkina-Sukhorukova NA; Tel'bukh VP; Stepanov VM
Prikl Biokhim Mikrobiol; 1984; 20(4):528-33. PubMed ID: 6433342
[TBL] [Abstract][Full Text] [Related]
7. Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments.
Morais JF; de Freitas MC; Yamaguchi IK; dos Santos MC; da Silva WD
Toxicon; 1994 Jun; 32(6):725-34. PubMed ID: 7940578
[TBL] [Abstract][Full Text] [Related]
8. Preparation of a novel antivenom against Atractaspis and Walterinnesia venoms.
Ismail M; Al-Ahaidib MS; Abdoon N; Abd-Elsalam MA
Toxicon; 2007 Jan; 49(1):8-18. PubMed ID: 17097125
[TBL] [Abstract][Full Text] [Related]
9. Initial volume of a drug before it reaches the volume of distribution: pharmacokinetics of F(ab')2 antivenoms and other drugs.
Sevcik C; Salazar V; Díaz P; D'Suze G
Toxicon; 2007 Oct; 50(5):653-65. PubMed ID: 17689580
[TBL] [Abstract][Full Text] [Related]
10. Enhanced pepsin digestion: a novel process for purifying antibody F(ab')(2) fragments in high yield from serum.
Jones RG; Landon J
J Immunol Methods; 2002 May; 263(1-2):57-74. PubMed ID: 12009204
[TBL] [Abstract][Full Text] [Related]
11. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
[TBL] [Abstract][Full Text] [Related]
12. Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography.
Raweerith R; Ratanabanangkoon K
J Immunol Methods; 2003 Nov; 282(1-2):63-72. PubMed ID: 14604541
[TBL] [Abstract][Full Text] [Related]
13. A reduced immunization scheme to obtain an experimental anti-Loxosceles laeta ("violinist spider") venom.
de Roodt AR; Litwin S; Dokmetjian JC; Vidal JC
J Nat Toxins; 2002 Aug; 11(3):193-203. PubMed ID: 12182539
[TBL] [Abstract][Full Text] [Related]
14. Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab')2 extrusion mechanism from blood to tissues.
Sevcik C; D'Suze G; Díaz P; Salazar V; Hidalgo C; Azpúrua H; Bracho N
Toxicon; 2004 Dec; 44(7):731-41. PubMed ID: 15500849
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic and immunochemical characterization of Bothrops insularis venom and its neutralization by polyspecific Bothrops antivenom.
Lira MS; Furtado MF; Martins LM; Lopes-Ferreira M; Santoro ML; Barbaro KC
Toxicon; 2007 Jun; 49(7):982-94. PubMed ID: 17382362
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
17. Purification of F(ab')2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield.
dos Santos MC; D'Império Lima MR; Furtado GC; Colletto GM; Kipnis TL; Dias da Silva W
Toxicon; 1989; 27(3):297-303. PubMed ID: 2728022
[TBL] [Abstract][Full Text] [Related]
18. Absorption and elimination of viper venom after antivenom administration.
Rivière G; Choumet V; Saliou B; Debray M; Bon C
J Pharmacol Exp Ther; 1998 May; 285(2):490-5. PubMed ID: 9580588
[TBL] [Abstract][Full Text] [Related]
19. Quantitative comparison on the refinement of horse antivenom by salt fractionation and ion-exchange chromatography.
Saetang T; Treamwattana N; Suttijitpaisal P; Ratanabanangkoon K
J Chromatogr B Biomed Sci Appl; 1997 Oct; 700(1-2):233-9. PubMed ID: 9390734
[TBL] [Abstract][Full Text] [Related]
20. Stability of the lyophilized F(ab')2 fragments of horse tetanus antibodies isolated by affinity chromatography.
Goch H; Schiller B; Korbecki M
Arch Immunol Ther Exp (Warsz); 1979; 27(4):499-509. PubMed ID: 42372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
